Novartis Ag (NVS) Current Taxes (2017 - 2025)
Novartis Ag (NVS) has disclosed Current Taxes for 9 consecutive years, with $2.0 billion as the latest value for Q4 2025.
- Quarterly Current Taxes rose 23.14% to $2.0 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.0 billion through Dec 2025, up 23.14% year-over-year, with the annual reading at $2.0 billion for FY2025, 23.14% up from the prior year.
- Current Taxes hit $2.0 billion in Q4 2025 for Novartis Ag, up from $1.6 billion in the prior quarter.
- In the past five years, Current Taxes ranged from a high of $2.5 billion in Q4 2022 to a low of $1.6 billion in Q4 2024.
- Historically, Current Taxes has averaged $2.1 billion across 5 years, with a median of $2.0 billion in 2025.
- Biggest five-year swings in Current Taxes: dropped 25.27% in 2023 and later grew 23.14% in 2025.
- Year by year, Current Taxes stood at $2.4 billion in 2021, then rose by 4.89% to $2.5 billion in 2022, then decreased by 25.27% to $1.9 billion in 2023, then fell by 15.53% to $1.6 billion in 2024, then increased by 23.14% to $2.0 billion in 2025.
- Business Quant data shows Current Taxes for NVS at $2.0 billion in Q4 2025, $1.6 billion in Q4 2024, and $1.9 billion in Q4 2023.